Minireview Magnetically controlled targeted micro-carrier systems

doi:10.1016/0024-3205(89)90593-6

Life Sciences

Volume 44, Issue 3, 1989, Pages 175-186

https://doi.org/10.1016/0024-3205(89)90593-6 Get rights and content

Abstract

Magnetically controlled targeted drug delivery systems are aimed at concentrating drugs at a defined target site, with the aid of a magnetic field. This technique has been developed specifically for directing drugs away from the reticuloendothelial system (RES). Literature on this topic suggests that these delivery systems are capable of altering the distribution of chemotherapeutic agents in the body. Hence these delivery devices offer the possibility of improving the therapeutic efficacy of the associated drugs. This paper reviews the work done to date towards the development and evaluation of biodegradable and non-biodegradable magnetic targeted drug delivery systems and outlines their future prospects and limitations in cancer chemotherapy.

References (110)

K.J. Widder et al.
K.J. Widder et al.
Pharmacol. Therap.
(1983)
D.F. Ranney
Biochem. Pharmacol.
(1986)
K.J. Widder et al.
Eur. J. Cancer Clin. Oncol.
(1983)
L.E. Gerlowski et al.
Microvas. Res.
(1986)
C.F. Driscoll et al.
Microvas. Res.
(1984)
M. Akimoto et al.
Biomaterials
(1983)
K. Mosbach et al.
FEBS Letters
(1979)
E.M. Gipps et al.
Int. J. Pharm.
(1987)
K. Widder et al.
J. Pharm. Sci.
(1979)

P.K. Gupta et al.

Int. J. Pharm.

(1986)

P.K. Gupta et al.

Int. J. Pharm.

(1988)

K.J. Widder et al.

Eur. J. Cancer Clin. Oncol.

(1983)

K. Sugibayashi et al.

Biomaterials

(1982)

G.M. Ihler

Pharmacol. Therap.

(1983)

D.A. Lewis et al.

Int. J. Pharm.

(1984)

C.R. Alving

Pharmacol. Therap.

(1983)

J.N. Weinstein et al.

Pharmacol. Therap.

(1984)

R.L. Juliano et al.

Biochem. Biophys. Res. Commun.

(1975)

T. Kato et al.

Lancet

(1979)

W. Sadee

Y.N. Lee et al.

Cancer

(1980)

M.S. Didolkar et al.

Ann. Surg.

(1978)

J.M. Collins

J. Clin. Oncol.

(1984)

U.G. Eriksson et al.

Acta Pharmacol. Toxicol. suppl.

(1986)

C. Collin et al.

H. Buchwald et al.

Cancer

(1980)

W. Ensminger et al.

Cancer Treat. Rep.

(1981)

J. Lokich et al.

J. Clin. Oncol.

(1983)

G. Cocconi et al.

D.F. Chiuten et al.

J. Lokich et al.

S. Yoneda et al.

Oncology

(1985)

S. Elakkad et al.

J. Khandekar et al.

U. Zimmermann et al.

Z. Naturforsch

(1976)

K.J. Widder et al.

A.E. Senyei et al.

J. Pharm. Sci.

(1981)

U. Schroder et al.

T. Kato

P.K. Gupta et al.

D.F. Ranney

Science

(1985)

N.R.G. Broadbent et al.

New Zealand Med. J.

(1985)

A. Senyei et al.

J. Appl. Phys.

(1978)

T. Kato et al.

IRCS Med. Sci.

(1979)

M. Akimoto et al.

J. Pharm. Dyn. suppl.

(1982)

Y. Morimoto et al.

Chem. Pharm. Bull.

(1982)

Y. Morimoto et al.

Chem. Pharm. Bull.

(1983)

K. Mosbach et al.

Enz. Engg.

(1981)

Cited by (202)

Temperature-directed fluorescent switchable nanoparticles based on P3OT–PNIPAM nanogel composite
2023, European Polymer Journal
Poly(N-isopropylacrylamide) (PNIPAM) is a unique stimuli-responsive material that exhibits a lower critical solution temperature (LCST). Owing to this characteristic temperature-dependent behavior, PNIPAM has found extensive utilization as an active material in various applications, including sensors, drug delivery, and cellular imaging. Herein, we demonstrate temperature-directed fluorescent switchable nanoparticles based on poly(3-octylthiophene-2,5-diyl) (P3OT) nanoaggregate-embedded PNIPAM nanogel composites (POPNs) featuring different crosslinker contents. The amount of P3OT loading in the nanogel composites can be gradually controlled by varying the crosslinking density of the PNIPAM matrix; this may be attributable to the efficient entrapment of P3OT nanoaggregates in case of a dense polymeric network with the increase in crosslinking density. POPNs exhibit dramatic temperature-dependent fluorescence enhancement (by a factor of 2.11). This is based on the environmental changes affecting fluorescent P3OT chains at temperatures below and above the LCST of the PNIPAM matrix. Based on this temperature-directed fluorescent switching capability, POPN could find potential applications in various fields, including biomedical imaging and sensors.
Density functional theory calculation on structures, electronic and magnetic properties of the Fe<inf>m</inf>O<inf>n</inf>C<inf>70</inf> and Fe<inf>m</inf>O<inf>n</inf>@C<inf>70</inf> (m=1–3, n=1–4) clusters
2023, Solid State Communications
The tendency of iron oxide molecules to adsorb or embed carbon cages is a more noteworthy issue in terms of cluster size. The structures, electronic and magnetic properties of the Fe_mO_nC₇₀ and Fe_mO_n@C₇₀ (m = 1–3, n = 1–4) clusters have been investigated by using first-principles. Iron oxide molecules prefer to be adsorbed rather than coated by C₇₀ cages. The chemical stability of FeOC₇₀ and Fe₂O₃C₇₀ clusters is higher than that of the corresponding FeO@C₇₀ and Fe₂O₃@C₇₀ clusters, while the chemical stability of Fe₃O₄C₇₀ clusters is lower than that of Fe₃O₄@C₇₀ clusters. A small amount of electrons (0.026 |e|∼0.205 |e|) are transferred from iron oxide molecules to C₇₀ cages except for Fe₃O₄@C₇₀ clusters. Spin densities of Fe atoms of the Fe_mO_nC₇₀ and Fe_mO_n@C₇₀ clusters decreases to zero except for the Fe₃O₄@C₇₀ clusters.
Surface functionalization of magnetic nanoparticles: potentials for biomedical applications
2022, Fundamentals and Industrial Applications of Magnetic Nanoparticles
Magnetic nanoparticles (MNPs) are widely used for myriad in vivo and in vitro biomedical applications via targeted drug delivery in cancer therapy, hyperthermia, photocatalysis, contrast enhancement magnetic resonance, antibacterial activity, etc. These applications are owing to their large surface area to the volume ratio. MNPs have become indispensable for in vivo therapeutic purposes, due to their easy binding with biomolecules such as proteins, enzymes, antibodies or nucleotides. All the in vivo biomedical applications require that the MNPs exhibit good saturation magnetization, particle size, morphology, and surface functionalization that is biocompatible and biodegradable. The various sizes of MNPs can be control through the synthesis procedures and the materials used for the surface functionalization which enables their comparison to biological organisms from cells, genes, proteins, and virus. In conclusion, the recent advances and future functionalization perspective in the development of MNPs for different biomedical applications will be summarized in this chapter.
Bio-inspired encapsulation and functionalization of iron oxide nanoparticles for biomedical applications
2020, European Polymer Journal
Cancer cells are typified by proliferating mass of cells that grow faster than other smaller cell tissues within the body. Efforts to combat this effect through chemotherapy, radiotherapy, immunotherapy and surgery are still challenging. Magnetic Iron oxide nanoparticles (FeO-NPs) encapsulated with biopolymers as a local drug delivery system with the control via an external magnetic field has been widely used as a drug delivery system in cancer therapy, minimizing the side effects and lack of pathological site-specific action common to the conventional approaches. For the FeO-NPs to function optimally in actualizing the applications as mentioned earlier, it requires that the FeO-NPs have high magnetization values, narrow particle size distribution and a special surface encapsulation. Biopolymers used for surface functionalization offer several advantages in biomedical applications, owing to their defined primary structures, nontoxicity, biocompatibility and biodegradability. The functionalized FeO-NPs offer various possibilities, which include targeting ligands, proteins, antibodies and covalent attachment of drugs using an external magnetic field for cancer therapeutic purposes. This work discusses recent advances in the development of FeO-NPs from fabrication to applications and the state-of-the-arts synthetic routes. The work gives special attention to the biopolymer surface functionalization of FeO-NPs now and future perspective of drug delivery in oncologic disease therapy chiefly cancer cells.
Core-shell nanoparticles and their use for in vitro and in vivo diagnostics
2018, Core-Shell Nanostructures for Drug Delivery and Theranostics: Challenges, Strategies and Prospects for Novel Carrier Systems
Due to their unique structure, the application potential of core-shell nanoparticles (NPs) in the field of biomedicine is huge. This includes in vitro and in vivo imaging, biosensing, separation and purification of biomolecules, drug delivery, and tumor therapy. A core-shell structure is used to improve biocompatibility and stability of NPs under physiological conditions, as well as to obtain multifunctionality such as multicolor, tunable luminescence, combination of magnetism, and luminescence or radioactivity by combination of different materials inside of a single particle. In this way, different detection methods can be operated simultaneously or even diagnosis and therapy may be combined. In this chapter a short overview of different synthesis techniques used for the preparation of various core-shell NPs systems is presented, NP properties are discussed, and finally typical applications of core-shell NPs in the field of diagnostics are shown.
Investigation of superparamagnetism in pure and chromium substituted cobalt nanoferrite
2016, Journal of Magnetism and Magnetic Materials
Nanostructured magnetic materials with the chemical composition CoFe₂O₄ and CoCr_0.9Fe_1.1O₄ were synthesized through Citrate-gel chemical synthesis with a crystallite size of 6.5 nm and 10.7 nm respectively. Structural characterization of the samples was performed by X-ray diffraction analysis and magnetic properties were studied using Vibrating Sample Magnetometer (VSM). Magnetization measurements as a function of applied magnetic field ±10 T at various temperatures 5 K, 25 K, 310 K and 355 K were carried out. Field cooled (FC) and Zero field cooled (ZFC) magnetization measurements under a magnetic field of 100 Oe for temperature ranging from 5–400 K were studied. The blocking temperature (T_b) for both the ferrites was observed to be around 355 K. Below blocking temperature they showed ferromagnetic behavior and above which they are superparamagnetic in nature that favors their application in the biomedical field. The substitution of paramagnetic Cr³⁺ ions for magnetic Fe³⁺ ion in cobalt ferrite has resulted in a decrease in magnetization and the coercivity of the samples. CoCr_0.9Fe_1.1O₄ nanoferrites with observed low coercivity of 338 Oe make them desirable in high frequency transformers due to their very soft magnetic behavior.

View all citing articles on Scopus

^§: Present address: Zenith Technology Corporation Limited, 156 Fredrick Street, P O Box 1777, Dunedin, New Zealand.

View full text

Aids research communicationMinireview Magnetically controlled targeted micro-carrier systems

Abstract

Pharmacol. Therap.

Biochem. Pharmacol.

Eur. J. Cancer Clin. Oncol.

Microvas. Res.

Microvas. Res.

Biomaterials

FEBS Letters

Int. J. Pharm.

J. Pharm. Sci.

Int. J. Pharm.

Int. J. Pharm.

Eur. J. Cancer Clin. Oncol.

Biomaterials

Pharmacol. Therap.

Int. J. Pharm.

Pharmacol. Therap.

Pharmacol. Therap.

Biochem. Biophys. Res. Commun.

Lancet

Cancer

Ann. Surg.

J. Clin. Oncol.

Acta Pharmacol. Toxicol. suppl.

Cancer

Cancer Treat. Rep.

J. Clin. Oncol.

Oncology

Z. Naturforsch

J. Pharm. Sci.

Science

New Zealand Med. J.

J. Appl. Phys.

IRCS Med. Sci.

J. Pharm. Dyn. suppl.

Chem. Pharm. Bull.

Chem. Pharm. Bull.

Enz. Engg.

Aids research communication
Minireview Magnetically controlled targeted micro-carrier systems